Skip to content

Asymchem Welcomes Franck Mevellec as Senior Director, Business Development

By API User

PARIS–BUSINESS WIRE– Asymchem, a leading global CDMO, is excited to announce the appointment of Franck Mevellec as senior director, business development. Franck brings over 20 years of experience in the pharmaceutical industry, working across various aspects of drug development from R&D to sales. Franck boasts a proven track record of success, having held key positions … Continued

JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89)

By API User

JJP Biologics has received a positive conclusion on the Clinical Trial Application assessment for a Phase I Study of a potential first-in-class anti-CD89 antagonist, JJP-1212 monoclonal antibody for the treatment of various IgA-mediated autoimmune- and fibrotic diseases. WARSAW, Poland–BUSINESS WIRE– JJP Biologics, a private biopharmaceutical company developing innovative antibody-based therapies, announces a positive decision, issued … Continued

Long-term prescription opioid use after hospital declining: study

By API User

UNSW Sydney medical researchers have shed light on post-hospital prescription opioid use. A large, linked data study has detailed the scale of prescription opioid use – such as oxycodone, morphine, or tramadol – after a hospital or emergency department (ED) visit, while giving insight into how often people then go onto long-term and potentially problematic … Continued

Cleo’s Ovarian Cancer Blood Test Outperforms Current Clinical Benchmark

By API User

  Highlights A benchmarking study comparing CLEO’s ovarian cancer blood test against ultrasound has been published in scientific journal “Cancers” The study confirmed that CLEO’s initial test for the surgical triage market:– Significantly outperforms current clinical workflows that use CA125 and ultrasound to predict malignancy;– Correctly detected 90% of early-stage cancers compared to only 50% … Continued

De-escalation VR training for behavioural emergencies set to revolutionise dementia education – on show today at Adelaide Convention Centre

By API User

In Adelaide today Dementia Australia unveiled D-Esc, a new innovative virtual reality (VR) training workshop for de-escalating a behavioural emergency in a care setting.         D-Esc provides an immersive simulation, designed for frontline and health care professionals, to adopt an interactive approach to de-escalation training. Participants will build empathy and understanding towards people with dementia, … Continued

Ferrer Obtains the Distribution Rights for Treprostinil Inhalation Solution Including the Potential Indications for Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF)

By API User

BARCELONA, Spain–BUSINESS WIRE– The international pharmaceutical BCorp company Ferrer continues to strengthen its focus on pulmonary vascular and interstitial lung diseases by announcing the expansion of its current distribution agreement with United Therapeutics Corporation (Nasdaq: UTHR) for Tyvaso® (treprostinil inhalation solution*) – a pharmaceutical drug-device combination product authorized for the treatment of WHO Group 3 … Continued

TOMORROW: South Australian D-Esc VR launch of new workshop for de-escalating a behavioural emergency in a care setting

By API User

Tomorrow, Dementia Australia unveils D-Esc to South Australia’s aged care sector, a new innovative virtual reality (VR) training workshop for de-escalating a behavioural emergency in a care setting.         D-Esc provides an immersive simulation, designed for frontline and health care professionals, to adopt an interactive approach to de-escalation training. Join us to experience D-Esc – the … Continued

Latest data confirms one in 12 Australians will be affected by blood cancer

By API User

On World Blood Cancer Day, Tuesday May 28, 2024, the Leukaemia Foundation unveiled shocking new statistics highlighting the widespread prevalence of blood cancer in Australia, underscoring that the nation is currently facing a significant blood cancer crisis.   According to latest figures, it’s estimated that eight percent of Australians will be diagnosed with blood cancer … Continued